The Relationship between Body Fat Percentage and Metabolic Syndrome Indices in Childhood Morbid Obesity

Authors: Mustafa M. Donma

Abstract:

Metabolic syndrome (MetS) is characterized by a series of biochemical, physiological and anthropometric indicators and is a life-threatening health problem due to its close association with chronic diseases such as obesity, diabetes mellitus, hypertension, cancer and cardiovascular diseases. The syndrome deserves great interest both in adults and children. Particularly, children with morbid obesity have a great tendency to develop the disease. The diagnostic decision is not so easy and may not be complete particularly in the pediatric population. Therefore, preventive measures should be considered at this stage. The aim of the study was to develop a MetS index capable of predicting MetS, while children are at the morbid obesity stage. This study was performed on morbid obese (MO) children, which were divided into two groups. MO children, who do not possess MetS criteria comprised the first group (n = 44). The second group was composed of children with MetS diagnosis (n = 42). Anthropometric measurements including weight, height, waist circumference (WC), hip C, head C, neck C, biochemical tests including fasting blood glucose (FBG), insulin (INS), triglycerides (TRG), high density lipoprotein cholesterol (HDL-C) and blood pressure measurements (systolic (SBP) and diastolic (DBP)) were performed. Body fat percentage (BFP) values were determined by TANITA’s Bioelectrical Impedance Analysis technology. Body mass index and MetS indices were calculated. Descriptive statistics including median values, t-test, Mann Whitney U test, correlation-regression analysis were performed within the scope of data evaluation using the statistical package program, SPSS. Statistically significant mean differences were determined by a p value smaller than 0.05. Median values for MetSI and ADMI in MO (MetS-) and MO (MetS+) groups were calculated as 25.9 and 36.5 and 74.0 and 106.1, respectively. Corresponding mean ± SD values for BFPs were 35.9 ± 7.1 and 38.2 ± 7.7 in groups. Correlation analysis of these two indices with corresponding general BFP values exhibited significant association with ADMI, close to significance with MetSI in MO group. Any significant correlation was found with neither of the indices in MetS group. In conclusion, important associations observed with MetS indices in MO group were quite meaningful. The presence of these associations in MO group was important for showing the tendency towards the development of MetS in MO (MetS-) participants. The other index, ADMI, was more helpful for predictive purpose.

Keywords: Body fat percentage, child obesity, metabolic syndrome index, morbid obesity.

References:

[1] Z. W. Bitew, A. Alemu, E. G. Ayele, Z. Tenaw, A. Alebel, and T. Worku, “Metabolic syndrome among children and adolescents in low and middle income countries: a systematic review and meta-analysis,” Diabetol. Metab. Syndr., vol. 12, pp. 93, Oct. 2020.
[2] Z. Bitew, A. Shitie, Z. Tenaw, A. Alebel, T. Kassie and E. Ayele, “Prevalence of metabolic syndrome among children and adolescents in high-income countries: A systematic review and meta-analysis of observational studies,” BioMed. Res. Int., vol. 2021, pp. 6661457, Mar. 2021.
[3] A. Bener, M. T. Yousafzai, S. Darwish, A. Q. Al-Hamaq, E. A. Nasralla and M. Abdul-Ghani, “Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio,” J. Obes., vol.2013, pp.269038, 2013.
[4] H. Jin and D. Benyshek, “The “metabolic syndrome index”: A novel, comprehensive method for evaluating the efficacy of diabetes prevention programs,” J. Diabetes Mellitus, vol.3, pp.96-99, 2013.
[5] M. M. Donma and O. Donma, “A new index for the differential diagnosis of morbid obese children with and without metabolic syndrome,” Int. J. Med. Health Sci., vol.17, no.2, pp.1, 2023.
[6] S. Mohseni-Takalloo, H. Mozaffari-Khosravi, H. Mohseni, M. Mirzaei and M. Hosseinzadeh, “Evaluating neck circumference as an independent predictor of metabolic syndrome and its components among adults: A population-based study,” Cureus, vol.15, no.6, pp.e40379, Jun. 2023.
[7] M. Solera-Martínez, S. López-Martínez, M. Sánchez-López, P. Moya-Martínez, B. Notario-Pacheco, N. Arias-Palencia, P. Franquelo-Morales, V. Martínez-Vizcaíno and Estudio de Cuenca Adultos, “Validity of a single-factor model underlying the metabolic syndrome in young adults: confirmatory factor analysis,” Rev. Esp. Cardiol. vol. 64, no. 5, pp.379-384, May 2011.
[8] A. Ramos-Jiménez, R. P. Hernández-Torres, A. Wall-Medrano and R. Villalobos-Molina, “Metabolomic (anthropometric and biochemical) indexes and metabolic syndrome in adolescents and young adults with intellectual disabilities,” Res. Dev. Disabil., vol. 35, no. 11, pp. 2987-2992, Nov. 2014.
[9] Q. Lu, C. Ma, F. Yin, R. Wang, D. Lou and X. Liu, “Blood pressure-to-height ratio as a screening measure for identifying children with hypertension,” Eur. J. Pediatr., vol.172, no.1, pp.99-105, Jan. 2013.
[10] A. Ahmed, S. W. Ali, S. Massodi and M. A. Bhat, “Blood pressure-to-height ratio as a screening tool for hypertension in children,” Indian Pediatr., vol.53, no.2, pp.137-139, Feb. 2016.
[11] G. Katamba, D. Collins Agaba, R. Migisha, A. Namaganda, R. Namayanja and E. Turyakira, “Using blood pressure height index to define hypertension among secondary school adolescents in southwestern Uganda,” J. Hum. Hypertens., vol.34, no.1, pp.76-81 Jan. 2020.
[12] G. Pérez-Gimeno, A. I. Ruperez, M. Gil-Campos, C. M. Aguilera, A. Anguita, R. Vázquez- Cobela, E. Skapino, L. A. Moreno, R. Leis and G. Bueno-Lozano, “Height-based equations as screening tools for high blood pressure in pediatric practice, the GENOBOX study,” J. Clin. Hypertens. (Greenwich), vol.24, no.6, pp.713-722, Jun. 2022.
[13] M. Yazdi, F. Assadi, S. S. Daniali, R. Heshmat, M. Mehrkash, M. E. Motlagh, M. Qorbani, and R. Kelishadi, “Performance of modified blood pressure-to-height ratio for diagnosis of hypertension in children: The CASPIAN-V study,” J. Clin. Hypertens. (Greenwich), vol.22, no.5, pp. 867-875, May 2020.
[14] R. Ramírez-Vélez, J. E. Correa-Bautista, A. Sanders-Tordecilla, M. L. Ojeda-Pardo, E. A. Cobo-Mejía, R. D. P. Castellanos-Vega, A. García-Hermoso, E. González-Jiménez, J. Schmidt-RioValle, and K. González-Ruíz, “Percentage of body fat and fat mass index as a screening tool for metabolic syndrome prediction in Colombian University students,” Nutrients, vol. 9, no. 9, pp. 1009, Sep. 2017.
[15] WHO World Health Organization (WHO). The WHO Child Growth Standards. Available at: http://www.who.int/childgrowth/en/ Accessed on June 10, 2016.
[16] P. Zimmet, K. G. Alberti, F. Kaufman, N. Tajima, M. Silink, S. Arslanian, G. Wong, P. Bennet, J. Shaw, S. Caprio, and IDF consensus group, “The metabolic syndrome in children and adolescents-an IDF consensus report,” Pediatr. Diabetes, vol.8, no.5, pp. 299-306, 2007.
[17] J. Q. Li, X. Wang, L. T. Peng, W. Yan, Q. Q. Liu, and X. N. Li, “The correlations of abdominal adipose tissue with anthropometric and metabolic parameters in obese children by magnetic resonance imaging,” Zhonghua Er. Ke. Za. Zhi., vol. 60, no. 8, pp. 798-803, Aug. 2022.
[18] S. Darroudi, N. Fereydouni, M. Tayefi, M. Ahmadnezhad, P. Zamani, B. Tayefi, J. Kharazmi, S. Tavalaie, A. Heidari-Bakavoli, M. R. Azarpajouh, G. A. Ferns, A. H. Mohammadpour, H. Esmaily, and M. Ghayour-Mobarhan, “Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome,” Biofactors, vol. 45, no. 1, pp. 35-42, Jan. 2019.
[19] N. Shah, A. Khadilkar, C. Oza, S. Bhor, D. Ladkat, K. Gondhalekar, C. More, and V. Khadilkar, “Adiponectin-leptin ratio as a marker of cardio-metabolic risk in Indian children and youth with type 1 diabetes,” J. Pediatr. Endocrinol. Metab., vol. 36, no. 6, pp. 561-567, May 2023.
[20] A. Boonyavarakul, C. Choosaeng, O. Supasyndh, and S. Panichkul, “Prevalence of the metabolic syndrome, and its association factors between percentage body fat and body mass index in rural Thai population aged 35 years and older,” J. Med. Assoc. Thai., vol. 88 Suppl. 3, pp. S121-130, Nov. 2005.
[21] M. Shukohifar, Z. Mozafari, M. Rahmanian, and M. Mirzaei, “Performance of body mass index and body fat percentage in predicting metabolic syndrome risk factors in diabetic patients of Yazd, Iran,” BMC Endocr. Disord., vol. 22, no. 1, pp. 216, Aug. 2022.
[22] J. C. Wong, S. O'Neill, B. R. Beck, M. R. Forwood, and S. K. Khoo, “Comparison of obesity and metabolic syndrome prevalence using fat mass index, body mass index and percentage body fat,” PLoS One, vol. 16, no. 1, pp. e0245436, Jan. 2021.
[23] P. Liu, F. Ma, H. Lou, and Y. Liu, “The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome,” BMC Public Health, vol. 13, pp. 629, Jul 2013.
[24] S. Zhu, Z. Wang, W. Shen, S. B. Heymsfield, and S. Heshka, “Percentage body fat ranges associated with metabolic syndrome risk: results based on the third National Health and Nutrition Examination Survey (1988-1994),” Am. J. Clin. Nutr., vol. 78, no. 2, pp. 228-235, Aug. 2003.
[25] Z. Miao, M. Alvarez, A. Ko, Y. Bhagat, E. Rahmani, B. Jew, S. Heinonen, L. L. Muñoz-Hernandez, M. Herrera-Hernandez, C. Aguilar-Salinas, T. Tusie-Luna, K. L. Mohlke, M. Laakso, K. H. Pietiläinen, E. Halperin and P. Pajukanta, “The causal effect of obesity on prediabetes and insulin resistance reveals the important role of adipose tissue in insulin resistance,” PLoS Genet., vol. 16, no. 9, pp. e1009018, Sep. 2020.
[26] R. D. Telford, R. B. Cunningham, J. E. Shaw, D. W. Dunstan, A. R. Lafferty, G. J. Reynolds, P. E. Hickman, E. Southcott, J. M. Potter, P. Waring, and R. M. Telford, “Contrasting longitudinal and cross-sectional relationships between insulin resistance and percentage of body fat, fitness, and physical activity in children-the LOOKstudy,” Pediatr. Diabetes, vol. 10, no. 8, pp 500-507, Dec. 2009.
[27] Y. H. Cheng, Y. C. Tsao, I. S. Tzeng, H. H. Chuang, W. C. Li, T. H. Tung, and J. Y. Chen, “Body mass index and waist circumference are better predictors of insulin resistance than total body fat percentage in middle-aged and elderly Taiwanese,” Medicine (Baltimore), vol. 96, no. 39, pp. e8126, Sep. 2017.
[28] L. B. Kurniawan, U. Bahrun, M. Hatta, and M. Arif, “Body mass, total body fat percentage, and visceral fat level predict insulin resistance better than waist circumference and body mass index in healthy young male adults in Indonesia,” J. Clin. Med., vol. 7, no. 5, pp. 96, May 2018.
[29] N. Macias, A. D. Quezada, M. Flores, M. E. Valencia, E. Denova-Gutiérrez, M. Quiterio-Trenado, K. Gallegos-Carrillo, S. Barquera and J. Salmerón, “Accuracy of body fat percent and adiposity indicators cut off values to detect metabolic risk factors in a sample of Mexican adults,” BMC Public Health, vol. 14, pp. 341, Apr. 2014.
[30] P. Mirmiran, M. Rezaei, G. Asghari, Y. Mehrabi and F. Azizi, “Association of metabolic syndrome with body fat percent, anthropometric indices in 10 to 18 year old adolescents,” Iran. J. Public Health, vol. 43, no. 2, pp. 93-201, 2014.
[31] P. Delgado-Floody, C. Álvarez, E. Lusa Cadore, M. Flores-Opazo, F. Caamaño-Navarrete, and M. Izquierdo, “Preventing metabolic syndrome in morbid obesity with resistance training: Reporting interindividual variability,” Nutr. Metab. Cardiovasc. Dis., vol. 29, no. 12, pp. 1368-1381, Dec. 2019.
[32] S. Dusanov, E. Heggen, and S. Tonstad, “Characteristics of metabolic syndrome in morbidly obese subjects,” Metab. Syndr. Relat. Disord., vol. 14, no. 10, pp. 500-506, Dec. 2016.
[33] F. J. Tinahones, L. Garrido-Sánchez, M. Murri, E. García-Fuentes, and F. Cardona, “Particular characteristics of the metabolic syndrome in patients with morbid obesity,” Endocrinol. Nutr., vol. 60, no. 3, pp. 127-135, Mar. 2013.
[34] B. Geloneze, J. A. Pereira, J. C. Pareja, M. M. Lima, M. A. Lazarin, I. C. Souza, M. A. Tambascia, E. Chaim, and E. Muscelli, “Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass,” Arq. Bras. Endocrinol. Metabol., vol. 53, no. 2, pp. 293-300, Mar. 2009.
[35] M. I. Fontalba-Romero, S. Lopez-Enriquez, A. Lago-Sampedro, E. García-Escobar, R. L. Pastori, J. Domínguez-Bendala, S. Álvarez-Cubela, S. Valdes, G. Rojo, E. Garcia-Fuentes, M. T. Labajos-Manzanares, and S. García-Serrano, “Association between the Mediterranean diet and metabolic syndrome with serum levels of miRNA in morbid obesity,” Nutrients, vol. 13, no. 2, pp. 436, Jan 2021.
[36] G. F. Adami, G. Ravera, G. M. Marinari, G. Camerini, and N. Scopinaro, “Metabolic syndrome in severely obese patients,” Obes. Surg., vol. 11, no. 5, pp. 543-545, Oct. 2001.
[37] J. B. Quintos, and S. Castells, “Management of metabolic syndrome in morbidly obese children and adolescents,” Pediatr. Endocrinol. Rev., vol. 3, Suppl. 4, pp. 564-570, Dec. 2006.
[38] C. L. Lafortuna, F. Adorni, F. Agosti, A. De Col, R. Zennaro, D. Caranti, and A. Sartorio, “Factor analysis of metabolic syndrome components in severely obese girls and boys,” J. Endocrinol. Invest., vol. 32, no. 6, pp. 552-558, Jun. 2009.
[39] K. S. Chong, Y. H. Chang, C. T. Yang, C. K. Chou, H. T. Ou, and S. Kuo, “Longitudinal economic burden of incident complications among metabolic syndrome populations,” Cardiovasc. Diabetol., vol. 23, no. 1, pp. 246, Jul. 2024.